Protalix Bio (PLX) Treats First Patient in PRX-112 Phase I
Tweet Send to a Friend
Protalix BioTherapeutics, Inc. (AMEX: PLX) announced that the first patient has been treated in the Company's phase I clinical trial ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE